日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]

使用氧化甘露聚糖-MUC1治疗早期乳腺癌患者的III期免疫疗法试点研究[ISRCTN71711835]

Apostolopoulos, Vasso; Pietersz, Geoffrey A; Tsibanis, Anastasios; Tsikkinis, Annivas; Drakaki, Heleni; Loveland, Bruce E; Piddlesden, Sara J; Plebanski, Magdalena; Pouniotis, Dodie S; Alexis, Michael N; McKenzie, Ian F; Vassilaros, Stamatis

Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement

单克隆抗体抑制补体膜抑制剂的功能,可诱导大鼠肾小管间质损伤。

Nomura, A; Nishikawa, K; Yuzawa, Y; Okada, H; Okada, N; Morgan, B P; Piddlesden, S J; Nadai, M; Hasegawa, T; Matsuo, S

A component of the medicinal herb ephedra blocks activation in the classical and alternative pathways of complement

药用植物麻黄的某种成分能够阻断补体经典途径和替代途径的激活。

Ling, M; Piddlesden, S J; Morgan, B P

Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement

从大鼠红细胞中分离并鉴定了一种膜蛋白,该蛋白能抑制大鼠补体膜攻击复合物引起的红细胞溶解。

Hughes, T R; Piddlesden, S J; Williams, J D; Harrison, R A; Morgan, B P